IHE, which allocates a combined 27.7% of its weight to Dow components Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE) and Merck (NYSE: MRK), has jumped 12.5% in the past six months. The fund could be an ideal play for conservative investors to use to profit from Obamacare. IHE’s three-year standard deviation of 11.99% is slightly lower than that of the iShares Core S&P 500 ETF (NYSEArca: IVV), according to iShares data.
iShares U.S. Pharmaceuticals ETF
ETF Trends editorial team contributed to this post.